Impact of Uterine and Ovarian Vessel Occlusion on Blood Loss in High Burden Minimally Invasive Myomectomy.

This study hypothesizes that temporary bilateral uterine and utero-ovarian artery occlusion with laparoscopic clamps at time of minimally invasive myomectomy will lead to a decreased blood loss at time of myomectomy compared to minimally invasive myomectomy without temporary occlusion.

Trial Details

NCT ID
NCT07182045
Phase
NA
Sponsor
The University of Texas Health Science Center, Houston
Status
RECRUITING
Cancer Type
Ovarian Cancer
Interventions
  • Temporary clamping of uterine and ovarian vessels
Locations (sample)
  • Houston, Texas, United States|29.76328,-95.36327

Key Eligibility Criteria

  • Patient undergoing minimally invasive myomectomy with either a single intramural or Submucosal fibroid =/\>5cm or
  • Patients undergoing minimally invasive Myomectomy with =/\> 5 fibroids

For full eligibility, visit ClinicalTrials.gov.

Check If You May Be Eligible

Trialify translates complex eligibility criteria into plain yes-or-no questions to help you understand if this trial might be right for you.

Find Ovarian Cancer Trials on Trialify →